Amphetamine sensitization elevates CaMKIIß mRNA

Recent studies have shown that the elevation in calcium/calmodulin‐dependent protein kinase II (CaMKII) may play an important role in amphetamine‐induced dopamine release, as well as in the increase of dopamine D2 receptor high‐affinitystates in psychosis. Because amphetamine sensitization is a wide...

Full description

Saved in:
Bibliographic Details
Published inSynapse (New York, N.Y.) Vol. 61; no. 10; pp. 827 - 834
Main Authors Greenstein, Rachel, Novak, Gabriela, Seeman, Philip
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent studies have shown that the elevation in calcium/calmodulin‐dependent protein kinase II (CaMKII) may play an important role in amphetamine‐induced dopamine release, as well as in the increase of dopamine D2 receptor high‐affinitystates in psychosis. Because amphetamine sensitization is a widely used animal model of psychosis or schizophrenia, we investigated whether amphetamine sensitization results in an overall increase in the α and β subunits of CaMKII. To answer this question, we measured CaMKII α and β subunit mRNA expression using Real‐Time Quantitative PCR in amphetamine‐sensitized rat striata, compared to saline‐treated controls. The results were then standardized to β‐glucuronidase, a housekeeping gene. Our results showed a statistically significant increase in the CaMKII β subunit, and an increase in the α subunit which did not reach statistical significance. Because the levels of both CaMKIIβ and CaMKIIα play a role in neuronal function and synapse formation, the present finding of an elevated level of CaMKII β and α subunit mRNA in the amphetamine‐sensitized model of psychosis points to the possibility of dysregulated levels of CaMKII subunits in human psychosis. Synapse 61:827–834, 2007. © 2007 Wiley‐Liss, Inc.
Bibliography:Ontario Mental Health Foundation (OMHF)
Essel Foundation
National Institute on Drug Abuse (NIDA)
ArticleID:SYN20429
Stephen Lieber
ark:/67375/WNG-QLNGRN0J-W
Stanley Medical Research Institute (SMRI)
National Alliance for Research on Schizophrenia and Depression (NARSAD)
Canadian Institutes for Health Research (CIHR)
istex:E7653E43B450A229EB20A85346C3E2CCCC266CD2
Constance Lieber
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-4476
1098-2396
DOI:10.1002/syn.20429